| |

Enhancing Research Quality: The Impact of the EQIPD Quality System Explored in the iRISE ProjectGoEQIPD publication describes

ByBjörn Gerlach

In our recent peer-reviewed article in Applied Neuroscience, we explore the implementation and potential benefits of the EQIPD Quality System in preclinical research. Despite numerous guidelines aimed at improving research practices, challenges remain, particularly in ensuring consistent quality and reproducibility across studies. The EQIPD Quality System was developed as a comprehensive and adaptable approach, designed…

A Systematic Assessment of Robustness in CNS Safety Pharmacology

ByBjörn Gerlach

We are thrilled to highlight another important contribution to the field of pharmacology by our EQIPD colleagues, along with a dedicated team of researchers. Their recent publication, “A Systematic Assessment of Robustness in CNS Safety Pharmacology,” appears in the British Journal of Pharmacology and addresses critical aspects of preclinical safety testing in the central nervous…

|

Reflections from the recent WCRI in Athens

ByBjörn Gerlach

I recently had the pleasure of presenting a poster at the World Conference on Research Integrity (WCRI) in Athens, which highlighted the significant changes and benefits that the EQIPD (Enhancing Quality In Preclinical Data) framework has brought to our research lab at the Central Institute of Mental Health (CIMH). The experience was both rewarding and…

Publication: Implementing the EQIPD Quality System

ByBjörn Gerlach

Members of the EQIPD consortium and working in preclinical research have published a manuscript on the EQIPD Quality System. The Journal of Neuroscience Methods article discusses the implementation of the EQIPD Quality System (QS) in non-regulated biomedical research to improve research practices and ensure data integrity. The EQIPD QS consists of 18 Core Requirements that…